Abstract
Every year more than one million new patients are diagnosed with colon cancer worldwide. Although multiple prospective randomized trials and observational studies have demonstrated that mortality from colon cancer can be reduced with screening and removal of adenomatous polyps, compliance with screening guidelines remains low. Recent CT colonography (CTC) trials have shown that CTC is capable of demonstrating adenomatous polyps -10mm (and in most cases -6 mm) with sensitivities comparable to those for optical colonoscopy. Based on these results, at least two expert panels have recommended CTC as an option for colorectal cancer screening. Despite these endorsements, the Centers for Medicare and Medicaid Services (CMS) in the United States recently decided to deny coverage of CTC for colorectal cancer screening. This article addresses the reservations raised by CMS and provides a perspective on whether CTC is ready for routine use as a colorectal cancer screening test.
| Original language | English (US) |
|---|---|
| Journal | Cancer Imaging |
| Volume | 9 |
| Issue number | SPEC. ISS. A |
| DOIs | |
| State | Published - Dec 1 2009 |
| Externally published | Yes |
Fingerprint
Keywords
- Colon, neoplasms
- Colon, polyps
- Colonoscopy
- Computed tomography colonography
- Rectum, neoplasms
- Rectum, polyps
- Virtual colonoscopy
ASJC Scopus subject areas
- Radiological and Ultrasound Technology
- Oncology
- Radiology Nuclear Medicine and imaging
Cite this
CT colonography screening : Ready for prime time? / Heiken, Jay.
In: Cancer Imaging, Vol. 9, No. SPEC. ISS. A, 01.12.2009.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - CT colonography screening
T2 - Ready for prime time?
AU - Heiken, Jay
PY - 2009/12/1
Y1 - 2009/12/1
N2 - Every year more than one million new patients are diagnosed with colon cancer worldwide. Although multiple prospective randomized trials and observational studies have demonstrated that mortality from colon cancer can be reduced with screening and removal of adenomatous polyps, compliance with screening guidelines remains low. Recent CT colonography (CTC) trials have shown that CTC is capable of demonstrating adenomatous polyps -10mm (and in most cases -6 mm) with sensitivities comparable to those for optical colonoscopy. Based on these results, at least two expert panels have recommended CTC as an option for colorectal cancer screening. Despite these endorsements, the Centers for Medicare and Medicaid Services (CMS) in the United States recently decided to deny coverage of CTC for colorectal cancer screening. This article addresses the reservations raised by CMS and provides a perspective on whether CTC is ready for routine use as a colorectal cancer screening test.
AB - Every year more than one million new patients are diagnosed with colon cancer worldwide. Although multiple prospective randomized trials and observational studies have demonstrated that mortality from colon cancer can be reduced with screening and removal of adenomatous polyps, compliance with screening guidelines remains low. Recent CT colonography (CTC) trials have shown that CTC is capable of demonstrating adenomatous polyps -10mm (and in most cases -6 mm) with sensitivities comparable to those for optical colonoscopy. Based on these results, at least two expert panels have recommended CTC as an option for colorectal cancer screening. Despite these endorsements, the Centers for Medicare and Medicaid Services (CMS) in the United States recently decided to deny coverage of CTC for colorectal cancer screening. This article addresses the reservations raised by CMS and provides a perspective on whether CTC is ready for routine use as a colorectal cancer screening test.
KW - Colon, neoplasms
KW - Colon, polyps
KW - Colonoscopy
KW - Computed tomography colonography
KW - Rectum, neoplasms
KW - Rectum, polyps
KW - Virtual colonoscopy
UR - http://www.scopus.com/inward/record.url?scp=77649212394&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77649212394&partnerID=8YFLogxK
U2 - 10.1102/1470-7330.2009.9025
DO - 10.1102/1470-7330.2009.9025
M3 - Article
C2 - 19965295
AN - SCOPUS:77649212394
VL - 9
JO - Cancer Imaging
JF - Cancer Imaging
SN - 1740-5025
IS - SPEC. ISS. A
ER -